Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Net Income (2022 - 2026)

Abpro Holdings' (ABPO) quarterly Net Income came in at -$983000.0 in Q1 2026, up 73.27% YoY from -$567335.0 in Q1 2025, and up 49.46% on a QoQ basis from -$1.9 million in Q4 2025.

Abpro Holdings (ABPO) Net Income (2022 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 5 years of Net Income data on file, last reported at -$983000.0 in Q1 2026.

  • Quarterly Net Income rose 73.27% year-over-year to -$983000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.9 million (up 6.77% YoY) and the FY2025 annual result came in at -$42.1 million, up 2.49% from the prior year.
  • Net Income grew to -$983000.0 in Q1 2026, from -$1.9 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $2.1 million in Q1 2023 to a low of -$3.7 million in Q1 2025.
  • A 5-year average of -$684899.9 and a median of -$338851.0 in 2024 frame the typical range for Net Income.
  • Annual changes were most pronounced in 2023 — Net Income surged 507.68% — and 2024, when it tumbled 42029.25%.
  • Tracing ABPO's Net Income over 5 years: stood at $1.5 million in 2022, then tumbled by 100.5% to -$7242.0 in 2023, then plunged by 42029.25% to -$3.1 million in 2024, then jumped by 36.25% to -$1.9 million in 2025, then soared by 49.46% to -$983000.0 in 2026.
  • The last three Net Income figures came in at -$983000.0 (Q1 2026), -$1.9 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 482.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -13.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Abpro Holdings 1.14 Mn 1.14 Mn - -1.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -983,000.00
Dec 31, 2025 -1.95 Mn
Sep 30, 2025 -1.54 Mn
Jun 30, 2025 -2.43 Mn
Mar 31, 2025 -3.68 Mn
Dec 31, 2024 -3.05 Mn
Sep 30, 2024 -335,100.00
Jun 30, 2024 -338,851.00
Mar 31, 2024 -1.05 Mn
Dec 31, 2023 -7,242.00
Sep 30, 2023 -44,630.00
Jun 30, 2023 802,803.00
Mar 31, 2023 2.07 Mn
Dec 31, 2022 1.46 Mn
Sep 30, 2022 652,421.00
Jun 30, 2022 -196,919.00
Mar 31, 2022 -1.03 Mn